Redmile Group, LLC - Aufsichtsrat - Tag der Transaktion: 2023-04-14...…
Redmile Group, LLC - Aufsichtsrat - Tag der Transaktion: 2023-04-14...…
New York, New York--(Newsfile Corp. - March 10, 2023) - The law firm of Kirby McInerney LLP announces that a…
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE),…
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 32.56% and 124.91%, respectively, for the quarter ended December 2022. Do…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ended 2022 with Approximately $475 Million in Cash, Cash Equivalents, and Receivables...…
New York, New York--(Newsfile Corp. - February 23, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds…
Los Angeles, California--(Newsfile Corp. - February 23, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
New York, New York--(Newsfile Corp. - February 22, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
Boston, Massachusetts--(Newsfile Corp. - February 22, 2023) - Block & Leviton announces that a class action lawsuit has been filed…
NEW YORK, Feb. 22, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…
NEW YORK, Feb. 21, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
New York, New York--(Newsfile Corp. - February 20, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. (NASDAQ:…
NEW YORK, Feb. 18, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
New York, New York--(Newsfile Corp. - February 18, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
LOS ANGELES, Feb. 17, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses…
New York, New York--(Newsfile Corp. - February 16, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
NEW YORK, Feb. 15, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…
NEW YORK, Feb. 14, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
New York, New York--(Newsfile Corp. - February 13, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…
San Diego, California--(Newsfile Corp. - February 10, 2023) - The law firm of Robbins Geller Rudman & Dowd LLP announces…
New York, New York--(Newsfile Corp. - February 10, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
New York, New York--(Newsfile Corp. - February 9, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
New York, New York--(Newsfile Corp. - February 8, 2023) - The securities litigation law firm of The Gross Law Firm…
NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
BENSALEM, Pa., Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have…
NEW YORK, Feb. 5, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
New York, New York--(Newsfile Corp. - February 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds…
New York, New York--(Newsfile Corp. - February 2, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class…
Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…
SAN DIEGO, Jan. 28, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate…
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
New York, New York--(Newsfile Corp. - January 27, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces…
Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…